1-6 of 6 results for subject:Streptococcus
Librarians' tools
- Search time
- 0.175 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Streptococcus
- We searched for
- subject_t:Streptococcus OR subject_t:"Strep A" OR subject_t:"Streptococcal infections" OR subject_ses:368447
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, how many babies aged 0-3 months died from group B Strep infection in 2019; and how many of those babies were BAME.
To ask the Secretary of State for Health and Social Care, how many babies aged 0-3 months died from group B Strep infection in 2019; and how many of those babies were BAME.
The data is not held in the format requested.
To ask the Secretary of State for Health and Social Care, what proportion of babies aged 0-3 months who developed group B Strep infection in 2019 were BAME.
To ask the Secretary of State for Health and Social Care, what proportion of babies aged 0-3 months who developed group B Strep infection in 2019 were BAME.
The data is not held in the format requested.
To ask the Secretary of State for Health and Social Care, what progress has been made on the Group B Streptococcus testing GBS3 trial; and when that trail is expecting to resume as covid-19 lockdown restrictions are eased.
To ask the Secretary of State for Health and Social Care, what progress has been made on the Group B Streptococcus testing GBS3 trial; and when that trail is expecting to resume as covid-19 lockdown restrictions are eased.
As a result of the COVID-19 pandemic, some aspects of the GBS3 trial were stopped temporarily, including the randomisation of sites to the different arms of the trial and recruitment of participants. However, the team continued with other research related tasks to ensure smooth site opening for the trial re-start.
Training, randomisation and opening of sites to the trial requires the full engagement of maternity and microbiology services. The GBS3 trial hopes to randomise the first sites in September and begin recruiting women early in 2021 but this is dependent on the status of services at the time. The National Institute for Health Research (NIHR) has set out the Restart Framework to guide the restart of NIHR research activities which is available at the following link:
To ask the Secretary of State for Health and Social Care, what plans the Government has to support Strep B Awareness Month from 1 July to 31 July 2020.
To ask the Secretary of State for Health and Social Care, what plans the Government has to support Strep B Awareness Month from 1 July to 31 July 2020.
Public Health England’s national programme Start4Life provides advice and practical guidance to parents-to-be and families with babies and under-fives, to help them adopt healthy behaviours and build parenting skills. The Start4Life website can be accessed at the following link:
Start4Life has been supporting Group B streptococcus Awareness month by posting from social media channels throughout July. The posts have been designed to raise awareness of Group B Strep, testing in pregnancy and the warning signs to look for in newborn babies.
Channels include Facebook, Instagram and Twitter. Start4Life has also been re-sharing posts made by Group B Strep Support, a United Kingdom charity.
To ask the Secretary of State for Health and Social Care, what proportion of women undertake a strep B test during pregnancy; and what plans his Department has to make that test compulsory for all pregnant women.
To ask the Secretary of State for Health and Social Care, what proportion of women undertake a strep B test during pregnancy; and what plans his Department has to make that test compulsory for all pregnant women.
The test that is used currently to detect strep B during pregnancy is the Asymptomatic Bacteriuria test, which is generally used to detect more common bacterial infections such as E. Coli and Klebsiella. The data on the number of women who undertake an Asymptomatic Bacteriuria test to identify strep B specifically is not collected.
The UK National Screening Committees last reviewed the evidence to introduce screening for Group B Strep (GBS) at 35 to 37 weeks of pregnancy in 2017 and concluded that there was insufficient evidence to demonstrate that the benefits of screening would outweigh the harms.
The National Institute for Health Research (NIHR) has commissioned a clinical trial to compare universal screening for GBS against usual risk-based care. This £2.8 million trial (GBS3 trial) was launched in April 2019 and is due to report after four years. The UK NSC will review its recommendation in light of the evidence from the trial, after it reports in 2023.